137 related articles for article (PubMed ID: 7690637)
1. Cystic fibrosis and endobronchial pseudomonas infection.
Høiby N
Curr Opin Pediatr; 1993 Jun; 5(3):247-54. PubMed ID: 7690637
[TBL] [Abstract][Full Text] [Related]
2. Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis.
Fiel SB
Chest; 1995 Feb; 107(2 Suppl):61S-64S. PubMed ID: 7842815
[TBL] [Abstract][Full Text] [Related]
3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
5. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa.
Høiby N
Neth J Med; 1995 Jun; 46(6):280-7. PubMed ID: 7643943
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
John M; Ecclestone E; Hunter E; Couroux P; Hussain Z
Pediatr Pulmonol; 1994 Aug; 18(2):108-13. PubMed ID: 7526323
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.
Dettelbach MA; Hirsch BE; Weissman JL
Otolaryngol Head Neck Surg; 1994 Oct; 111(4):528-32. PubMed ID: 7524007
[No Abstract] [Full Text] [Related]
8. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
10. Infectious complications of lung transplantation. Impact of cystic fibrosis.
Flume PA; Egan TM; Paradowski LJ; Detterbeck FC; Thompson JT; Yankaskas JR
Am J Respir Crit Care Med; 1994 Jun; 149(6):1601-7. PubMed ID: 7516251
[TBL] [Abstract][Full Text] [Related]
11. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients.
Nunley DR; Grgurich W; Iacono AT; Yousem S; Ohori NP; Keenan RJ; Dauber JH
Chest; 1998 May; 113(5):1235-43. PubMed ID: 9596300
[TBL] [Abstract][Full Text] [Related]
12. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
Richards RM; Hamilton VE; Thomas MR
J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
[TBL] [Abstract][Full Text] [Related]
13. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.
Döring G; Conway SP; Heijerman HG; Hodson ME; Høiby N; Smyth A; Touw DJ
Eur Respir J; 2000 Oct; 16(4):749-67. PubMed ID: 11106223
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
16. Microbiology of lung infection in cystic fibrosis.
Govan JR; Nelson JW
Br Med Bull; 1992 Oct; 48(4):912-30. PubMed ID: 1281036
[TBL] [Abstract][Full Text] [Related]
17. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
Langan KM; Kotsimbos T; Peleg AY
Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
[TBL] [Abstract][Full Text] [Related]
18. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
Al-Aloul M; Crawley J; Winstanley C; Hart CA; Ledson MJ; Walshaw MJ
Thorax; 2004 Apr; 59(4):334-6. PubMed ID: 15047956
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Pukhalsky AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Shabalova LA; Kokarovtseva SN; Pukhalskaya DA; Kashirskaja NJ; Simonova OI
Mediators Inflamm; 1999; 8(3):159-67. PubMed ID: 10704054
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis.
Noyes BE; Michaels MG; Kurland G; Armitage JM; Orenstein DM
Chest; 1994 Jun; 105(6):1888-91. PubMed ID: 7515778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
